Ultimovacs Balance Sheet Health
Financial Health criteria checks 5/6
Ultimovacs has a total shareholder equity of NOK191.0M and total debt of NOK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NOK215.8M and NOK24.8M respectively.
Key information
0%
Debt to equity ratio
NOK 0
Debt
| Interest coverage ratio | n/a |
| Cash | NOK 131.00m |
| Equity | NOK 191.01m |
| Total liabilities | NOK 24.78m |
| Total assets | NOK 215.79m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7UM's short term assets (NOK140.1M) exceed its short term liabilities (NOK12.3M).
Long Term Liabilities: 7UM's short term assets (NOK140.1M) exceed its long term liabilities (NOK12.5M).
Debt to Equity History and Analysis
Debt Level: 7UM is debt free.
Reducing Debt: 7UM had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 7UM has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 7UM has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 22% each year.